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Cocaine (25 mg/kg i.p.) produces analgesia in the rat within 5 min and for a duration of 90 min as determined by the formalin test or 
for 30 min as determ.ined by the hot plate test. Cocaine analgesia is unaffected by doses of naloxone that are sufficient to attenuate 
morphine analgesia in both tests. Chlorpromazine (3 mg/kg i.p.), SCH 23390 (100/~g/kg i.p.; a D 1 dopamine receptor antagonist), and 
eticlopride (75 ~g/kg i.p.; a D 2 dopamine receptor antagonist) each attenuate cocaine analgesia in both tests at doses that alone do not 
affeet performance in either test. Measurements of blood pressure and heart rate indicate that cocaine analgesia is not due to the acti- 
vation of baroreceptor reflex afferents. We conclude that cocaine is a supraspinally acting, dopamine-mediated, non-opiate analgesic 
in the :"at. 
INTRODUCTION 
The central nervous system action of systemically 
administered analgesic compounds is thought to be 
mediated primarily, if not exclusively, by neural 
mechanisms also activated by opiate receptors 12'!8. 
Neurons containing norepinephrine and serotonin 
form essential connecting links in the opiate-acti- 
vated analgesia mechanism ~2,35. Because cocaine 
blocks the deactivating re-uptake of biogenic amines 
in the central nervous system 3°.32, we considered that 
cocaine might have potent systemic analgesic proper- 
ties. Furthermore, cocaine's action could bypass 
opiate receptor mechanisms because it is not an 
opiate narcotic. ~t has long been known that sympa- 
thomimetic agents can produce analgesia 5,25, but we 
found only 3 short anecdotal reports on the analgesic 
effect of systemically administered cocaine in 
dogs 2°'27 and a human ~6. Yang et al. ~6 showed that co- 
caine applied intranasally attenuated ischemic pain 
(tourniquet test) in humans, but this effect could not 
be related securely to a systemic action, and opiate 
mediation was not tested. We therefore undertook a 
systematic investigation of cocaine as a systemic an- 
algesic. 
MATERIALS AND METHODS 
All experiments were conducted using male Spra- 
gue-Dawley  rats (250-400 g) maintained in facilities 
fully accredited by the American Association for the 
Accreditation of Laboratory Animal Care. 
Analgesia was evaluated by both the formalin and 
hot plate tests. In the formalin test 9, 0.05 ml of sterile 
5% formalin was injected subcutaneously into the 
dorsum of one forepaw. Every 5-10 min, pain behav- 
ior was graded throughout a 3 min observation pe- 
riod according to the proportion of time (seconds) 
the paw was held up and licked (grade 3), held fully 
elevated (grade 2), partially weight bearing (grade 
1), or fully weight bearing (grade 0). The sum of the 
products of each grade and the time spent in that 
grade was divided by 180 s to yield a pain intensity 
score. In the hot plate test 22, each rat was placed 
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within a clear plexiglass cylinder on a copper surface 
maintained at 52.5 °C by circulating water. The la- 
tency to hind paw lick or escape was determined and 
the test was terminated after 45 s. The baseline laten- 
cy (B) was the average of 3 latency measurements 
made at 5 mi~l intervals before administering drugs. 
Latencies (L) measured at intervals after drug ad- 
ministration were used to calculate % analgesia 
(=[(L-B)I(45-B)] x 100). The significance of differ- 
ences in pain scores (formalin test), % analgesia (hot 
plate test), or cardiovascular measurements was 
evaluated by computing the 95% confidence inter- 
vals about each mean. Compared means were con- 
sidered significantly different when each fell outside 
the confidence limit of the other. 
To determine if drug-induced motor deficits inter- 
fered with the hot plate test, we used the abnormal 
posture test of Fog 13. One hindpaw of the rat was 
placed on a cork with a height of 3.5 cm, and the la- 
tency to movement off the cork was measured up to a 
maximum of 45 s. 
Blood pressure and heart rate responses to cocaine 
or saline wer¢ determined in 13 rats. Five days before 
the experiment, rats were surgically implanted with a 
chronic polyethylene cannuia (PE50) in the left inter- 
nal carotid artery. The cannula was exteriorized at 
the scalp and passed through a stainless-steel spring, 
which was anchored to the skull with dental acrylic 
and screws. Blood pressure was recorded directly in 
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Fig. 1. Effect of different intraperitoneal doses of cocaine on 
averaged (_+ S.E.M.) pain intensity ratings in the formalin test. 
Formalin (5%, 0.05 ml) was injected subcutaneously into one 
forepaw 30 rain before 0 time on the abscissa. Cocaine was ad- 
ministered at time 0. Four rats were in each dosage group. 
Riled diamonds, 5 mg/kg, open squares, l0 mg/kg; filled 
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Fig. 2. Lack of effect of naloxone (1 mg/kg, i.p.) on cocaine (25 
mg/kg, i.p.) analgesia. Top: formalin test in blinded format. At 
time 0, 30 min after subcutaneous formalin injection, each rat 
received 2 separate injections within 1 min. Average (_+ 
S.E.M.) pain ratings shown for each group of rats receiving co- 
caine and saline (n = 9), cocaine and naloxone (n = 9), saline 
and naloxone (n = 10), and saline only (n = 8). Bottom: hot  
plate test. Average (_+ S.E.M.) % analgesia (see Methods) 
shown for rats receiving cocaine (n = 8) or cocaine followed im- 
mediately by naloxone (n = 8) at time 0. 
polygraph and Statham P23 pressure transducers. 
• Heart rate was counted from the pressure tracing. 
Cardiovascular parameters were monitored for 15 
min before administration of cocaine (25 mg/kg i.p.) 
or saline (1 ml/kg i.p.). Blood pressure was mon- 
itored continuously for 40 min after treatment and 
heart rate was sampled over 20 s epochs at 1, 5, 15, 25 
and 40 min after treatment. 
All drugs were given by intraperitoneal injection. 
Cocaine was prepared in sterile 25 mg/mi multiple in- 
jection vials by the pharmacy at the Veterans Admin- 
istration Medical Center. The concentration of co- 
caine was independently verified on two occasions by 
the Toxicology Laboratory at the University of Mi- 
chigan. The prototype dopamine D~ and D 2 receptor 
antagonists, SCH 23390 and eticlopride, respective- 
ly, were both obtained from Research Biochemicals 
(Natick, MA). Fresh solutions in bacteriostatic saline 
were prepared daily; SCH 23390 was first dissolved 
in a minimum volume of 10% acetic acid. 
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RESULTS 
Cocaine injected intraperitoneally produced a 
dose-dependent analgesia as determined in 20 rats by 
the formalin test (Fig. 1). At maximally effective 
doses (20-25 mg/kg, i.p.), analgesia was clearly de- 
tectable within 5 min and sustained for I -1.5 h in 
most rats. During the analgesic period, rats showed a 
slight to moderate increase in exploratory behavior 
that did not interfere with execution of the test. 
Otherwise, behavior appeared normal and without 
evidence for weakness or ataxia. Cocaine (25 mg/kg, 
i.p.) also produced analgesia as determined by the 
hot plate test (Fig. 2). The response peaked at 5-10 
rain but, in contrast with the formalin test, the dura- 
tion of analgesia was limited to approximately 30 
min. In preliminary experiments using the tail flick 
test 6, we found that the higher doses of cocaine pro- 
duced, in the awake, restrained rat, enough in- 
creased spontaneous movement to make measure- 
ments unreliable (data not shown). 
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Fig. 3. Effect of naloxone (1 mg/kg, i.p.) on morphine analge- 
sia. Top: formalin test. Arrows indicate time of drug injection. 
Morphine (6 mg/kg, i.p.; n = 5) produces analgesia more slow- 
ly than cocaine (25 mg/kg, i.p,; n = 9) and, unlike cocaine, 
morphine analgesia is attenuated by naloxone. Bottom: hot 
plate test. Morphine (12 mg/kg, i.p.) analgesia (n = 7) fails to 
develop when naloxone (1 mg/kg, i.p.) is injected immediately 
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Fig. 4. Chlorpromazine (CPZ; 3 mg/kg, i.p.) attenuation of co- 
caine (25 mg/kg, i.p.) analgesia in the formalin test. CPZ and 
cocaine were separately administered within one minute after 
time 0. CPZ alone had no effect (n = 6). n = 15 (cocaine alone) 
and 12 (CPZ and cocaine). 
Naloxone had no effect on cocaine analgesia in 
either the formalin or hot plate test (Fig. 2). In the 
formalin test, a blind format was used to test 36 rats 
divided into 4 groups; neither the person preparing 
the solutions nor the person performing the test knew 
which treatment any rat received. The dose of na!ox- 
one we used (1 mg/kg) was sufficient to attenuate 
morphine analgesia in both formalin and hot plate 
tests (Fig. 3). 
Because of the evidence that other behavioral ef- 
fects of cocaine are mediated in part by dopaminergic 
mechanisms 33, we determined the effect of the dopa- 
mine receptor antagonist, chlorpromazine (CPZ) on 
cocaine analgesia. When administered at a dose of 3 
mg/kg, i.p., CPZ alone had no effect on the formalin 
test of pain behavior but significantly reduced the in- 
tensity and duration of cocaine analgesia (Fig. 4). 
To examine further the dopamine receptor mecha- 
nisms that might mediate cocaine analgesia, rats 
were pretreated with either SCH 23390, a D l selec- 
tive antagonist 17 or eticlopride, a D2 selective antag- 
onist s. In the formalin test (Fig. 5), both SCH 23390 
(100 gg/kg, i.p.) and eticlopride (75 /~g/kg, i.p.) 
blocked the analgesic effect of cocaine at doses that 
alone had no effect on the test. In the hot plate test 
(Fig. 6), eticlopride and SCH 23390 both significantly 
attenuated cocaine analgesia; neither of these dopa- 
mine receptor antagonists interfered with the hot 
plate test when administered alone at the above 
doses. In addition, these compounds produced no 
evidence of motor impairment as assessed by the ab- 
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Fig. 5. D i receptor antagonist, SCH 23390 (SCH, 100/zg/kg, 
i.p., top panel), and D 2 receptor antagonist, eticlopride (E, 
75.5/~g/kg, i.p., bottom panel), given 10 min before cocaine (25 
mg/kg, i.p.), each prevent cocaine analges;.a without affecting 
the formalin test when given alone. Arrows indicate time of 
drug injection, n = 4 (SCH alone), 3 (SCH + cocaine), 4 (E 
alone), 3 (E + cocaine), and 6 (cocaine alone). 
corresponding to the block of cocaine analgesia. 
There is evidence that acutely increasing arterial 
blood pressure in rats can produce an analgesia that 
is correlated with the reflex bradycardia  mediated by 
baroreceptor  activation 1°'25. Analgesic  doses of co- 
caine produced a significant increase in systolic blood 
pressure within the first minute after  the injection, 
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Fig. 6. Hot plate test. Eticlopride (E; 75.5 pg/kg, i.p.) and SCH 
23390 (SCH; 100 ,ug/kg, i.p.) each block cocaine (25 mg/kg, 
i.p.) analgesia when given 10 min before cocaine injection at 
time 0. n = 14 (SCH + cocaine), 15 (E + cocaine), 12 (cocaine 
+ saline), and 6 (saline). Asterisks indicate points of significant 
attenuation of cocaine analgesia. 
309 
showed no difference compared  to animals injected 
with saline (Fig. 7). The  transient hypertension was 
accompanied by a significant bradycardia for  only 5 
min. 
D I S C U S S I O N  
The analgesic effect of systemically administered 
cocaine has been demonst ra ted  in this study by two 
different measures of supraspinally organized noci- 
fensive behaviors. The formalin test elicits a pro-  
longed behavioral response to a chemically-induced 
inflammation,  whereas the hot plate test elicits a 
short  duration,  abrupt  response to a thermal stimu- 
lus. By both measures,  analgesia elicited by 20-25  
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Fig, 7. Cardiovascular effects of cocaine (25 mg/kg, i.p.). Co- 
caine (n = 7) or saline (n = 6) was injected at time O. Top: co- 
caine (circles) significantly increased systolic blood pressure at 
I rain after injection compared to saline-treated controls (trian- 
gles). Systolic pressure before injection: cocaine group, 125 _+ 
9 mm Fig; saline group, 132 _+ 7 mm Fig. Bottom: cocaine de- 
creased heart rate at 1-5 min after injection compared to con- 
trols. Heart rate before injection: cocaine group, 369 _+ 35 
bpm; saline group, 423 _ 32 bpm. There were no significant 
differences in pretreatment blood pressure or heart rate be- 
tween treatment groups. Asterisks indicate means that are sig- 
nificantly different from zero change and from the means of sa- 
line controls. 
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mg/kg of cocaine appears comparable in intensity to 
the analgesia produced by 6-12 mg/kg of morphine; 
at these doses, the analgesic effect of cocaine is more 
rapid in onset and, in the hot plate test, shorter in du- 
ration (Fig. 3). However, a definitive comparison of 
the potency and efficacy of these two analgesics will 
require additional studies asing several dosage levels 
of each drug. 
Our results indicate that the analgesia produced by 
?arenterally administered cocaine is due to its action 
an nociceptive mechanisms within the central ner- 
vous system. We saw no evidence for motor deficits 
that would be expected if peripheral motor or kines- 
thetic mechanisms were affected by local anesthetic 
block. The attenuation and reversal of cocaine anal- 
gesia by dopamine antagonists also argues for a cen- 
tral effect on monoaminergic synaptic transmission 
rather than local anesthetic block of conduction in 
peripheral fibers. Furthermore, other experiments in 
our laboratory have shown that analgesic parenteral 
doses of cocaine do not affect the conduction of im- 
pulses into the cutaneous terminals of unmyelinated 
nociceptive afferents 23. The same dose of cocaine 
dramatically alters, over a time course paralleling the 
behavioral effects, the spontaneous and nociceptive- 
ly evoked activity of bulboreticular neurons that pro- 
ject rostraUy or to the spinal cord 1. It is possible, 
however, that the more prolonged analgesic effect of 
cocaine in the formafin, as compared to the hot plate, 
test is in part due to a peripheral anti-gnflamraatory 
effect of adrenal steroids in view of the recent finding 
that cocaine causes the release of adrenocorticotrop- 
ic hormone in vitro 28. 
Systemic cocaine analgesia appears not to be 
caused by the activation of baroreceptors. In our ex- 
periments, cocaine produced a transient hyperten- 
sion but did not induce the prolonged bradycardia as- 
sociated with baroreceptor-activated analgesia ~°,25. 
Similar results have been reported by others 24. A dis- 
sociation of cardiovascular responses and analgesia 
has recently been demonstrated during vaginocervi- 
cal probing and phenylephrine injection in the rat 3. 
Furthermore, naloxone reverses the analgesia of 
chronically hypertensive rats without affecting the 
blood pressure 37, but naloxone had no effect on co- 
caine analgesia in our eJtperiments. We cannot, how- 
ever, rule out the possibility that cocaine produces 
other somatic or viscera' afferent activity that con- 
tributes to the activation of central analgesic mecha- 
nisms 26,3s. 
Our results provide strong evidence that both Dl 
and D 2 dopamine receptor mechanisms are impor- 
tant in mediating cocaine analgesia because both the 
D 2 receptor antagonist, eticlopride, and the D1 re- 
ceptor antagonist, SCH 23390, blocked cocaine anal- 
gesia in both the formalin and hot plate tests. In the 
formalin test, an anti-analgesic effect of both com- 
pounds might be seen if they each attenuated any 
anti-inflammatory effects of cocaine 28. Because of 
the evidence for synergistic interactions of D1 and D 2 
receptor mechanisms 4, it is not possible to conclude 
that these two receptor types are acting independent- 
ly in mediating cocaine analgesia. A more complete 
analysis of agonist and antagonist dose-response 
functions will be required to determine receptor se- 
lectivity. Furthermore, a spinal or supraspinal anal- 
gesic action of other monoamine systems cannot be 
excluded on the basis of our studies. 
The central neural mechanisms of cocaine analge- 
sia remain to be determined. De Jong et al. 7 and 
Woolf and Wiesenfeld-Hallin 34 have presented evi- 
dence that systemically administered local anesthet- 
ics selectively block C-fiber-evoked polysynaptic re- 
flex activity in the spinal cord. The results of other 
experiments in our laboratory, however, suggest a 
supraspinal site for cocaine analgesia because anal- 
gesic doses of cocaine either potentiate or have no ef- 
fect on a nociceptive spinal reflex 23. The lack of evi- 
dence for spinal reflex inhibition and the lack of na- 
loxone antagonism also argues against an opiate-me- 
diated activation of supraspinal mechanisms that in- 
hibit spinal nociceptive neurons by descending path- 
ways 12'14. The dose of naloxone we used was suffi- 
cient to attenuate morphine analgesia in our tests and 
has been shown to blcck analgesia mediated by both 
/~- and 6-opiate receptors II. Because cocaine is 
known to block the re-uptake deactivation of biogen- 
ic amines 29"3°, it might potentiate opiate analgesia, as 
shown by Misra et al. 21, by enhancing the bulbospi- 
hal, biogenic amine-mediated inhibition of nocifen- 
sire spinal reflexes 35. In contrast with our results, 
however, this potentiating effect of cocaine is 
blocked by naloxone 21. 
Evidence reviewed by Jensen 19 shows that dopa- 
mine mechanisms can inhibit spinal nocifensive re- 
flexes, but whether this inhibition is mediated by seg- 
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mental  spinal or  by supraspinal descending dopamine 
pathways is not known. Dopam~ne-mediated inhibi- 
tion of  spinal reflexes may be independent  of supra- 
spinal dopamine  neurons; we have shown that exten- 
sive chronic partial  myelotomies marked ly  reduce 
spinal serotonin and norepinephrine,  but  not dopa- 
mine,  concentrat ions in the cat 2. The effect of  co- 
caine on supraspinally media ted behaviors  and the 
dependence of  cocaine analgesia on dopaminergic  
mechanisms suggests the participation of  dopamine-  
containing mesolimbic structures,  which have been 
shown to be important  for maintaining cocaine self- 
administrat ion and reinforcement  in the rat  33'39. The 
role of hypothalamic-related structures in dopamine-  
mediated analgesia deserves fur ther  investigation in 
view of a recent report  that  cocaine causes the re- 
lease of adrenocorticotropic hormoae  ( A C T H )  
through the activation of  corticotropin releasing fac- 
tor  (CRF)  28. There are additional,  though con- 
flicting, reports about  the analgesic effects of  
CRFIS, 31" 
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